1. Home
  2. KEQU vs CRDF Comparison

KEQU vs CRDF Comparison

Compare KEQU & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • CRDF
  • Stock Information
  • Founded
  • KEQU 1906
  • CRDF 1999
  • Country
  • KEQU United States
  • CRDF United States
  • Employees
  • KEQU N/A
  • CRDF N/A
  • Industry
  • KEQU Medical Specialities
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KEQU Industrials
  • CRDF Health Care
  • Exchange
  • KEQU Nasdaq
  • CRDF Nasdaq
  • Market Cap
  • KEQU 124.6M
  • CRDF 144.4M
  • IPO Year
  • KEQU N/A
  • CRDF N/A
  • Fundamental
  • Price
  • KEQU $44.74
  • CRDF $2.23
  • Analyst Decision
  • KEQU
  • CRDF Strong Buy
  • Analyst Count
  • KEQU 0
  • CRDF 5
  • Target Price
  • KEQU N/A
  • CRDF $11.10
  • AVG Volume (30 Days)
  • KEQU 15.3K
  • CRDF 765.0K
  • Earning Date
  • KEQU 09-10-2025
  • CRDF 11-06-2025
  • Dividend Yield
  • KEQU N/A
  • CRDF N/A
  • EPS Growth
  • KEQU N/A
  • CRDF N/A
  • EPS
  • KEQU 4.13
  • CRDF N/A
  • Revenue
  • KEQU $263,183,000.00
  • CRDF $545,000.00
  • Revenue This Year
  • KEQU N/A
  • CRDF N/A
  • Revenue Next Year
  • KEQU N/A
  • CRDF N/A
  • P/E Ratio
  • KEQU $10.58
  • CRDF N/A
  • Revenue Growth
  • KEQU 30.09
  • CRDF N/A
  • 52 Week Low
  • KEQU $30.33
  • CRDF $1.90
  • 52 Week High
  • KEQU $71.33
  • CRDF $5.64
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 33.47
  • CRDF 52.32
  • Support Level
  • KEQU $43.33
  • CRDF $1.99
  • Resistance Level
  • KEQU $46.70
  • CRDF $2.27
  • Average True Range (ATR)
  • KEQU 1.22
  • CRDF 0.10
  • MACD
  • KEQU -0.40
  • CRDF 0.05
  • Stochastic Oscillator
  • KEQU 17.52
  • CRDF 91.67

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: